Psoriatic arthritis is a chronic inflammation of the joints that occurs in some people with a chronic skin and nail condition known as psoriasis. Psoriasis causes flare-ups of raised patches of skin covered with silvery scales. The onset of psoriasis may occur at any age but is most commonly seen between the ages of 15 and 50 years. Psoriatic arthritis can be noted before or after the skin lesions appear.
People with psoriasis may develop arthritis that causes destruction of various joints. The lining of the joint, the synovium, becomes inflamed. It reacts by producing extra synovial fluid, resulting in a swollen joint. The smooth white surface of the joint, the hyaline cartilage, can become thin, worn, and rough.
Psoriatic arthritis occurs only in people with underlying psoriasis. Psoriasis occurs more often in people of European ancestry. Approximately 5% to 8% of people with psoriasis will develop this form of arthritis. It affects men and women equally.
While the exact cause of psoriatic arthritis is unknown, several factors are suspected to be triggers for the disease. These factors include the following:
Both psoriasis and psoriatic arthritis flare up in people with HIV, the immunodeficiency disorder associated with AIDS.
Following are some of the signs and symptoms of psoriatic arthritis:
There are 5 main types of psoriatic arthritis. The most common type affects the small joints of the fingers and toes. Joints of the arms and legs, as well as bones of the spine, may also be affected by psoriatic arthritis.
The diagnosis is made by identifying the typical symptoms of arthritis in a person with psoriasis. Blood tests, including a complete blood count, or CBC, may be done to rule out other diseases such as rheumatoid arthritis or gout. Joint X-rays may show severe erosion of joints.
In some people, the degree of skin psoriasis may be minimal. Careful examination is required to detect even small areas of psoriasis.
There is no known way to prevent the development of psoriatic arthritis in someone who is prone to it.
Individuals who have psoriatic arthritis may have progressive destruction of the affected joints. This can lead to disfigurement and disability. Approximately 20% of people with psoriatic arthritis will have a severe course of disease.
Psoriatic arthritis is not contagious and poses no risk to others.
Much of the joint damage may appear in the beginning stages of the disease. For this reason, early treatment of psoriatic arthritis may be critical.
Following are medications used to treat psoriatic arthritis:
Other treatments for psoriatic arthritis may include:
Exercise is important in the treatment of arthritis. Thirty minutes of moderate exercise a day can help to prevent complications of arthritis, as well as heart disease, stroke, and diabetes. A person exercising at a moderate level can talk normally without shortness of breath and is comfortable with the pace of the activity. The 30 minutes a day can be done in one session, or it can be broken up into smaller segments. Low impact aerobics and water aerobics are examples of exercises that minimize joint stress.
Surgery may be performed when pain cannot be controlled or function is lost. Common procedures include the following:
There has been a great deal of interest lately in the use of glucosamine and chondroitin, dietary supplements that may decrease joint pain associated with arthritis. A large scale study is currently being conducted by the National Center for Complementary and Alternative Medicine and the National Institute of Arthritis and Musculoskeletal Disease to determine the effectiveness of these supplements.
Medications used to treat psoriatic arthritis may cause stomach upset, allergic reaction, decreased resistance to infection, and other side effects. Surgery may cause bleeding, infection, or allergic reaction to anesthesia. Nearby bones, ligaments, tendons, nerves, or blood vessels can also be accidentally injured.
Treatment of rheumatoid arthritis is lifelong. There is no cure for the disease, but careful management can help to minimize some of its effects. Periodic flare-ups of the disease are common.
A healthcare provider will monitor the person's level of comfort and function of the joint. Any new or worsening symptoms should be reported to the healthcare provider.
Author:Bill Harrison, MD
Date Written:
Editor:Ballenberg, Sally, BS
Edit Date:02/28/01
Reviewer:Barbara Mallari, RN, BSN, PHN
Date Reviewed:07/13/01
The Merck Manual of Medical Information, Home edition, 1997
Professional Guide to Diseases, Sixth Edition. Springhouse: Springhouse Corporation, 1998
Tierney, Lawrence, editor, "Current Medical Diagnosis and Treatment, 39th edition", 2000